|
|
|
Insider
Information: |
Canute Scott A |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
285,409 |
|
Indirect Shares
|
24,034 |
|
|
Direct
Value |
$22,988,442 |
|
|
Indirect Value
|
$20,123,428 |
|
|
Total
Shares |
309,443 |
|
|
Total
Value |
$43,111,870 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
President, Mfg. Operat... |
2007-02-01 |
25,367 |
2007-02-01 |
24,034 |
Premium* |
|
Genzyme Corp |
GENZ |
Executive VP |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
Outlook Therapeutics Inc |
OTLK |
Director |
2016-11-28 |
246,342 |
|
0 |
Premium* |
|
Immunomedics Inc |
IMMU |
Director |
2020-10-23 |
0 |
2018-04-02 |
0 |
Premium* |
|
Akebia Therapeutics, Inc. |
AKBA |
|
2019-06-06 |
13,700 |
2019-06-06 |
0 |
Premium* |
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2020-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
President, Mfg. Operations |
|
2005-06-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
6 |
14,480 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. Operations |
|
2005-08-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,091 |
3,953 |
|
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. Operations |
|
2005-08-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
0 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. Operations |
|
2006-06-13 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,293 |
18,078 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. OperationsOffi |
|
2004-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,036 |
|
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. OperationsOffi |
|
2004-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
OTLK |
Outlook Therapeutics Inc |
Director |
|
2016-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,463 |
|
- |
|
OTLK |
Outlook Therapeutics Inc |
Director |
|
2016-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
57,971 |
|
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. Operations |
|
2005-08-03 |
4 |
OE |
$23.41 |
$162,840 |
D/D |
6,000 |
9,953 |
|
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. Operations |
|
2005-08-16 |
4 |
OE |
$23.40 |
$162,600 |
D/D |
6,000 |
6,753 |
|
- |
|
GENZ |
Genzyme Corp |
Executive VP |
|
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
OTLK |
Outlook Therapeutics Inc |
|
|
2016-11-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,971 |
188,934 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Mfg. Operations |
|
2005-08-15 |
4 |
S |
$53.30 |
$170,564 |
D/D |
(3,200) |
753 |
|
- |
|
38 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|